Research Progress on Strategies that can Enhance the Therapeutic Benefits of Mesenchymal Stromal Cells in Respiratory Diseases With a Specific Focus on Acute Respiratory Distress Syndrome and Other Inflammatory Lung Diseases. (2021)
Attributed to:
Mesenchymal stem cell-derived extracellular vesicles as a cell-free therapy for ARDS.
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.3389/fphar.2021.647652
PubMed Identifier: 33953680
Publication URI: http://europepmc.org/abstract/MED/33953680
Type: Journal Article/Review
Volume: 12
Parent Publication: Frontiers in pharmacology
ISSN: 1663-9812